Anticoagulants Improve Survival Rates in Patients With COVID-19

An article published on our sister website Practical Cardiology reported on results from a new study that found improved survival rates in patients with coronavirus disease 2019 (COVID-19) treated with anticoagulants.

According to the study, which was led by researchers from the Mount Sinai COVID Informatics Center, hospitalized patients with COVID-19 had improved outcomes both in and out of the intensive care unit setting, without a significant difference in bleeding.

Internal server error